Managing questions related to this grant
We will post anonymised answers to any questions we receive on this page.
These Q&A are updated on a regular basis. We endeavour to answer new questions within one week of receiving them.
Note that if a question is submitted that is identical to a question previously answered, we will not release it.
Please check if a question you have has not already been answered within the Q&As before submitting.
If you have a new question, send it to us via Ask questions about the Ārohia Full Grant.
Applications
Please add the cost to both boxes e.g. if your total overseas activities including marketing are $10,000 and overseas marketing is $5,000 you will have $10,000 in the overseas box and $5,000 in the marketing box.
Cash flow has now been updated and corrected version loaded.
2. Also RE Cash Flow template, question 4.4.1 specifies requirement for "including forecasts on the amount of money we will spend on key operations such as marketing, sales...". There is only 1 line for Operating Expenses in the template, assume you are happy for us to butcher your template and add rows to satisfy this question? Or would like us to simply describe and articulate assumptions and not quantify those costs?
1. We are comfortable that your opening balance will be an estimation and you may also upload supporting evidence in terms of current cash holdings and expected revenue/outflows between now and 1 November if you wish.
2. Please describe/articulate the assumptions. Thank you.
How are the number of customers and conversion rate relevant when the cashflow period is for the innovation project when we are completing pre-market launch activities (ie not in market)?
Are you wanting to understand the forecast after we have launched the product? ie should we include forecasts for once we are 'in market' ie after the 2 year period.
If your innovation activities are for 24 months and are all pre-launch then the cashflow does not need to include revenue assumptions relating to the sale of the innovation. You may wish to include such information if your pre-launch period/grant period is less than 24 months in order to complete the two years of the cash flow.
For the cashflow we will use this to assess your ability to support the project. Please include your full business expenditure and expected cash inputs from any capital raising or shareholding funding and include expected costs and inflows from your Ārohia related activities. If you intend to only uptake the grant for 12 months a projection only over that time would be acceptable however we may require you to update this should you need to utilise the full 24 months of the contract. The total project expenditure across your project work sheet and cashflow should align.
With respect to forecast financial information all we require is a cashflow forecast for your business including the impacts of your project - you can use our template for this. As part of due diligence we also require Balance Sheet, P&L and supporting evidence for capital raising or additional shareholder funding.
You can apply a second time if you are unsuccessful the first time for each innovation and for each grant, however if you are declined for the Seed Grant you may wish to consider your preparedness for a Full Grant application.
Yes, as you need to demonstrate you can fund the project in its entirety between the grant and your co-funding.
We cannot guarantee that the Screening Committee and Grant Evaluation Panel will have a deep understanding of every area of expertise.
For this reason, it may be best to ensure that your application and pitch is presented in a way that is able to be understood by a wider audience. This is often good practice for any investor engagement.
Your ANZIC code is what is applicable to the business entity you are applying under.
We aren't able to provide answers to questions relating to specific applications.
However, the assessors will assess applications in line with the assessment framework based on how strong the reach and impact of those benefits are.
A pdf version of the application form questions is available on our website here. However, to gain access via the online portal, you must first speak to a Navigator or Funding Engagement Specialist.
If you wish to apply for the Full Grant in this first funding round, you will need to have begun a Full Grant application in IMS. Please note that having access to IMS does not meet this requirement, as a Full Grant application may not have been started.
If you don't start a Full Grant application by 28 July 2023, you won't be able to submit an application for this round. However, you will be able to submit a fresh application when the next round opens in early 2024.
Please note that applications must be completed and submitted by midday 24 August to be considered for this first assessment round.
Yes.
The application process is still contestable at the pitch stage. The purpose of the pitch has two parts. The content of the pitch and any Q&A that follows from the Panel helps them contribute to the application assessment. It also has a number of benefits for the applicant.
These include:
-
- An opportunity to describe challenging aspects that are difficult to relay in written form
- The process mirrors what is out in the investment ecosystem. By going through this process, applicants will know what to expect elsewhere
- It allows the applicant to receive direct, verbal feedback from the Panel, and written feedback with the benefit of back-and-forth Q&A.
- Facetime with high profile Panel members who are well known in the business world - Having become a finalist results in promotion opportunities through Callaghan Innovation, recognising an applicant's achievement in making it to the live pitch event.
Yes.
The timeline for processing the Full Grant is set out on our website here.
However if your question is how long will it take to complete the application form, we are unable to advise on this as it will depend on how fully prepared you are for the questions. You can view the application form here.
Yes, those who do not make it through the initial screening will receive feedback on their application from the Screening Committee.
Applicants who are progressed to the shortlist (and Panel event) will not receive feedback on their application from the Screening Committee. Instead, they will receive written feedback from the Grant Evaluation Panel, as well as the output of the independent research on potential benefits to the innovation ecosystem prior to the Panel event.
Yes, multiple applications can be submitted provided they are for different innovations
Any notes taken from the panel meeting will be used towards determining a recommendation to the final approvers within Callaghan Innovation. However it is not intended that the pitch sessions will be recorded.
You may nominate a start date but it cannot be before the date of the Grant Evaluation Panel meeting, and no more than six months after this date.
Your application can be submitted once per funding round and you have up to two opportunities to apply for the same innovation. We encourage you to be completely confident in your application prior to submission. You may wish to use the maximum amount of time available to consider and review your application before submission. Applications are assessed together only after the application round is closed so you won't receive any feedback from us prior to the application close off date.
Not as the process currently stands. If you are intending to apply for the Full Grant, and still have gaps in your knowledge of your innovation or its target market that need to be resolved, we strongly recommend that you consider applying for the Seed Grant. The Seed Grant is there to help you produce a quality application for the Full Grant. It's also worth reminding potential applicants that as the process currently stands, you are only allowed a maximum of two attempts at an application for the same idea. It may be wasteful to make an application if you're not yet ready.
Yes, you have two opportunities to apply with the same innovation.
You may still have a Seed Grant active while applying for the Full Grant. However, you must close it before you can receive a signed Funding Agreement for the Full Grant. As with all our grants, you cannot claim for duplicate costs across multiple applications.
Yes. There is no limit to the number of applications one entity can submit. However each application must be for a different innovation.
Eligible Activities
Does this mean we can only apply for this funding to target one geographic market, or one customer segment in our launch?
Or is this in reference to our overall innovation for which we are apply for funding? (ie we can include all activities that go towards launching this innovation to market, in whatever geographies or customer segment may be relevant?)
This is in reference to the overall innovation - activities are eligible up to the point you fully launch in your first market, whichever market(s) they may be. Once you have launched in a market (whether NZ or overseas) we consider further expansion into additional markets to be internationalisation which is beyond the scope of this grant - Please contact NZTE for support with internationalisation.
The COGS item in the cash flow forecast template is to show the COGS of the sales revenue, both business-as-usual items. The grant helps fund eligible activities involved in taking new innovation to the market for the first time. The costs are only eligible if they directly related to the approved innovation project, not business-as-usual activities. If you are already accounting for cost of goods sold, you need to ask yourself whether the innovation is already in the market, which makes it ineligible.
Yes, if the pre-launch/beta customers pay to use your prototype, then you can claim the net cost to construct/use a prototype (i.e. after subtracting the amount customers have paid to use it).
Materials and consumables used to develop a prototype are to be charged at cost (i.e. no mark-up). Where these costs sit depends on the nature of the prototype. If the prototype or demonstrator includes items of machinery, equipment or tools that have an enduring value beyond the project term, then you can claim the net cost to construct a prototype (i.e. after subtracting the cost of machinery, equipment or tools used that have an enduring value). The cost of machinery, equipment or tools used that have an enduring value should be claimed separately as depreciable plant or equipment items.
Registered design costs are eligible under Full Grant but not under Seed Grant.
R&D is what’s defined as R&D under the R&D Tax Incentive (RDTI); Activity that seeks to resolve a scientific or technological uncertainty, and any supporting activity that’s integral to resolving that uncertainty.
Please refer to the RDTI website for more information.
The distinction is on a costs basis - while performing R&D you may be incurring costs to overcome technological uncertainties (R&D) while also incurring other costs which are not R&D but essential to the success of your innovation such as patenting. While patenting is something you often do to secure your IP which resulted from R&D it's not an eligible R&D cost for the purposes of funding - this is where Arohia can help alongside the likes of RDTI which is R&D focused.
Yes, providing it's essential to taking the innovation to market and does not negate benefits to the NZ innovation ecosystem. Refer to the eligible activities guidance on page 11 for more information.
The distinction is on a costs basis - while performing R&D you may be incurring costs to overcome technological uncertainties (R&D) while also incurring other costs which are not R&D but essential to the success of your innovation such as patenting. While patenting is something you often do to secure your IP which resulted from R&D it's not an eligible R&D cost for the purposes of funding - this is where Arohia can help alongside the likes of RDTI which is R&D focused.
Clinical trials are generally covered under R&D funding mechanisms such as RDTI. There are however elements that sit around clinical trials such as patent filing, pre-production preparation, non-clinical end user testing and channel development (such as reimbursment strategy development and execution) are eligible under Arohia.
Yes provided they are paid by the business. Check out the eligible costs in our guide.
These costs would fall under capital expenditure rules with the exception of costs that relate to new regulation specific to your innovation, e.g. in the first instance, a resource consent for a retaining wall or factory would sit under capital expenditure rules (providing it was essential to the innovation), whereas gaining a resource consent because an activity is novel or facing new regulatory hurdles would be an eligible cost.
Refer to the eligible activities guidance for detailed information on what costs are eligible.
Refer to the eligible activities guidance for detailed information on what costs are eligible.
Broadly yes, innovation can be the combination of known existing offerings to deliver new value to market. It will be up to you to state a clear case for why your combination is novel and creates benefits to the New Zealand innovation ecosystem.
Yes. Refer to the eligible activities guidance on page 9 for more information.
Your business may be undertaking R&D but you cannot use Ārohia Grant funding for R&D expenses (you can however be receiving support for R&D through New to R&D or RDTI).
- Refer to the Full Grant eligible activities guidance for more information.
- Refer to the Seed Grant eligible activities guidance for more information.
Yes, providing it's essential to taking the innovation to market and does not negate benefits to the NZ innovation ecosystem. Refer to the eligible activities guidance on page 11 for more information.
Correct. We would note that R&D in this instance is as per RDTI definitions which is limited to activities that contain a core of research seeking to overcome a technological uncertainty - this is narrower than the accounting definition of R&D. There are many areas of development and non technological research that sit between the overcoming of a technological uncertainty and getting an innovation to market - these are the activities which Ārohia seeks to support.
Overheads can be charged at 20% of internal labour costs. Refer to the eligible activities guidance for more information.
Essentially R&D as per the RDTI definition is activities that seek to overcome a technological uncertainty and the essential activities which support them. For more information on R&D activities suitable for RDTI, refer to the RDTI website or page 32 of the RDTI guidance document.
There are many activities on an innovation journey that fall outside these such as market testing, demonstrator units, etc. Refer to the Full Grant eligible cost guidance for more information on both eligible activities as well as delineation between R&D and more general innovation activities.
Eligible Entities
Entities that are owned by the government are ineligible for this funding. We suggest you talk to us about your specific proposal so that we can understand the details, alternatively refer to the eligible entities guidance for more information.
Yes, Limited Partnerships are eligible. Refer to the eligible entities guidance for more information.
Overseas owned companies are eligible for the grant provided that the benefits flow to the New Zealand innovation ecosystem. If your ownership changes during the course of the grant, we will undertake an assessment to ensure the benefits remain. Refer to the eligible entities guidance for more information.
The Ministerial Direction sets out the requirements for eligible entities. If the company is registered and incorporated under the Companies Act 1993 then it will be eligible. Charitable trusts and unincorporated charities are not eligible. Refer to the eligible entities guidance for more information.
Funding
Question: Can investor funding be staggered or does the whole of funding need to be in place within the six months?
Answer: We will accept contractual agreements for tranched funding so you don't have to have the money in the bank but you must have contractual agreements in place. You have up to six months from the date you sign the funding agreement to secure the additional funding, but you must have a robust plan in place to do so when you apply. We will not pay any claims until the funding has been secured.
This answer is not clear.
The phrase “you must have contractual agreements in place” is different from “you have six months (after being awarded and signing) to secure the additional funding” is completely different.
Clarification would be welcomed, particularly the minimum you are looking for us to have achieved/in place by close of the application phase (24th August)
At the time of application you must have a plan in place to raise funds but you do not need to have these in place. If you are successful you then have up to six months to secure contractual agreements for this funding - it is at this point that your funding will become active. To reiterate you don't have to have the funding in place to apply and be approved but you must have the funding in place (at least contractually) within six months of being approved in order to activate your grant.
We recognise that uncertainty exists in taking any new innovation to market. We cannot fund you in excess of the initially approved total funding envelope however your contract will be for 24 months and you can move costs between objectives in consultation with us.
Yes - the New to R&D can cover your R&D and Ārohia can cover how you will deliver benefits to the innovation ecosystem.
You cannot be in the market with the specific innovation at the time of application. Pre-sales and paid pre-market trials are fine to be undertaken and supported with Ārohia funds however once the innovation is fully in market your funding would cease. The intent of Ārohia is to support companies seeking to take their innovation to market for the first time hence we wouldn't continue to fund you through this scheme once you were in market.
You will need to demonstrate that you can fund your 70% share of the costs. If you have already secured funding this will need to be shown in the application.
This will either need to be funds you have already secured, or you will need to have a robust plan on how you intend to source it.
Your 70% share of co-funding must be monetary. 'In kind' contribution will not be considered.
Full financial due diligence will be conducted incorporating a review of your Balance Sheet, Profit & Loss, Cash flow forecast and any supporting documentation that demonstrates how you will raise the funding you will require if you do not already have sufficient cash reserves to fund your share.
Your 70% share of co-funding must be monetary. 'In kind' contribution will not be considered.
The Seed grant is to help you with evidence to support your Full grant application, it is not intended to definitively answer the full grant questions or execute on your project.
We will accept contractual agreements for tranched funding so you don't have to have the money in the bank but you must have contractual agreements in place by the end of those six months. You have up to six months from the date you sign the funding agreement to secure the additional funding, but you must have a robust plan in place to do so when you apply. We will not pay any claims until the funding has been secured.
You may or may not incur all the costs that you state in your application. Any underspend can just not be claimed however, you cannot increase the amount of the grant once it has been approved.
If that investment contributes to the cash on your balance sheet, then yes, however investment in kind will not count. It would be expected that assets already owned by the business are not included in costs in the grant application.
We will accept contractual agreements for tranched funding so you don't have to have the money in the bank but you must have contractual agreements in place by the end of those six months. You have up to six months from the date you sign the funding agreement to secure the additional funding, but you must have a robust plan in place to do so when you apply. We will not pay any claims until the funding has been secured.
No. With the exception of equity investment you cannot use other government funding to co-fund this grant.
No. You must be able to demonstrate that you can cover your 70% of costs. In kind contributions cannot be included as costs.
No. With the exception of equity investment you cannot use other government funding to co-fund this grant.
The Grant Evaluation panel will need to be confident that you can cover your 70% share of the costs over the two year period. Your strategy to raise capital will need to be robust.
You can have them at the same time but you can't apply the funding to the same activities i.e. stack the funding support.
Yes that is acceptable.
You will need to demonstrate that you can fund your 70% share of the costs. If you have already secured funding this will need to be shown in the application.
No. Availability of funding is not a specific assessment criteria that is scored and will not influence whether a grant is awarded, provided an applicant can demonstrate they either have funding secured or have a robust plan to achieve funding.
You will need to demonstrate that you can fund your 70% share of the costs. If you have already secured funding this will need to be shown in the application.
This would depend on the circumstances and whether there is any opportunity to either adjust costs or raise further funding. If this were to happen, we would expect to enter into discussions with you regarding the way forward.
If that investment contributes to the cash on your balance sheet, then yes, however investment in kind will not count.
No - costs are only eligible from the start date of the grant.
The funding model we have to manage on behalf of the government dictates this way of operationalising the funds.
We will accept contractual agreements for tranched funding so you don't have to have the money in the bank but you must have contractual agreements in place by the end of those six months. You have up to six months from the date you sign the funding agreement to secure the additional funding, but you must have a robust plan in place to do so when you apply. We will not pay any claims until the funding has been secured.
One of the features on the full grant is that you can have up to six months after approval to raise the additional funds required and we will accept investment contracts in place of actual cash in the bank. Both Arohia Grants are co-funding grants so you must raise the remaining funds yourself - we have deliberately aligned much of the application process to standard capital raising approaches with the aim of reducing duplication of work for you in this space. Funding claims can be made as often as every two weeks during the project to ensure you're receiving funds as soon as possible after spending on your project.
Correct, this also includes any costs where the activity has not yet taken place but was booked and paid for prior to the grant start date (e.g. travel, conference).
Providing the funding is not from another government fund (apart from NZGCP investment) it's up to you where you source your funding. You have up to six months from the date you sign the funding agreement to secure the additional funding, but you must have a robust plan in place to do so when you apply. However, we will not pay any claims until the funding has been secured.
The Full Grant co-funding is rebated (claimed in arrears with proof of expenditure).
Grant Recipients
We must publish recipient, project title and amount of funding received on all approved funding. We are keen to support recipients to find ways to promote their work and gain beneficial exposure - we will work with customers on a case by case basis.
The usual start date of the grant will be the date of the Grant Evaluation Panel meeting, however, consideration may be given to a delayed start date of up to 6 months if requested. Start dates cannot be backdated.
The end date of the grant will be two years from the start date. Funding will cease at that point even if your innovation strategy is not complete.
Yes. We recognise that not all innovations will get to market within the two year timeframe so your project may be a subset of the overall milestones of a larger project or journey to market.
Grant Delivery
Yes, you may apply twice for the same innovation if you are unsuccessful the first time.
The next round opens in early 2024. Please refer to our website.
Given the cut-off date for new Full Grant applications was on 28 July 2023, you will not be able to apply for this particular round of the Full Grant.
The Seed Grant will continue to remain open and accept applications, so this will still be available to you in order to help you resolve any uncertainties before applying for the Full Grant in the next funding round.
In general there is no rule preventing you from applying for the Seed Grant and Full Grant at the same, for the same innovation.
However, if you apply for a Full Grant and Seed Grant at the same time for the same idea, you will not receive tailored advice on either application. This is likely to disadvantage you, especially given you will have uncertainties that you are wanting to resolve in order to put your best foot forward for the Full Grant. It is also worth reminding that you are allowed two attempts to apply for each innovation.
We're unable to provide dates or details on Panel members yet, as we are still undergoing the procurement process.
However, we can say that the Panel will be made up of a number of individuals with diverse experience across the innovation and investment ecosystems. The majority of the members will be external to Callaghan Innovation.
Keep an eye on our website, as we will provide updates and short biographies of our Panel members when we have confirmed them.
That date is for Full Grant. Seed Grant will continue to be open and will continuously accept applications.
Seed Grant will still be relevant for those who want to prepare for the next Full Grant funding round.
The grant funding will cease either at the end of the 2 year period or when you have completed all of the objectives in your work plan and have claimed the applicable costs for those activities - Whichever is sooner.
Note that only activities that aid you getting into market for the first time (whether this is locally or overseas) are eligible therefore you shouldn't have any post-market entry costs in your work plan.
The next round will open in early 2024. This is noted on the website. When we know further details about future rounds, we will also post these on the website.
Yes, the next round will open in early 2024.
We are still working through how often we can open funding rounds but we can confirm the next funding round will open in early 2024.
A number of factors will influence how many grants are awarded, including timing of funding rounds, value of grants awarded compared to available funding and complexity of assessment. At this stage we are unable to confirm how many grants will be awarded annually.
Seed Grant
We are agnostic to the specific content of the FTO - you should engage with your IP advisor on this. We do note that support in this place must be carried out by a registered patent attorney (whether patentability is a consideration or not).
Foreign and local provisional applications are eligible under seed. First filings are ineligible for seed but can be covered by full grant if you are successful.
The aim of the Seed Grant is to enable you to gather evidence to help you make a Full Grant application.
The aim of the Seed Grant is to enable you to gather evidence to help you make a Full Grant application. It will not necessarily mean you will have everything you need. You will need to make an assessment as to whether you are sufficiently prepared to apply for the Full Grant. Refer to our website to see the questions.
The timeline for both grants is very different. The Seed Grant is open for applications all the time. You may submit any time. Applications are assessed every two weeks in batches. The Full Grant is a longer and more onerous application and assessment process. Refer to the website to view the timeline for Full Grant.
For the Seed Grant, the Application Form asks for an attestation that you can fund your 50% share upfront. You will not need to provide any financial information to support this.
Yes. There is no limit to how many applications that one entity can submit. However, they must all be for different innovations, and you cannot claim for duplicate costs across multiple applications.
The Innovation Ecosystem
There is no current Callaghan Innovation grant that provides special consideration to Māori in the innovation ecosystem.
You will need to demonstrate that licensing the IP will enable other innovators to create something new themselves e.g. a new process or product as a direct result of your innovation.
The innovation ecosystem is the network of people, organisations and resources in Aotearoa New Zealand that together enable innovative ideas to be formed, supported, adopted and spread. One way to think about this is what is something that your project/innovation will do that will make it easier for future innovators like you to be successful. Creation of jobs and more exports are economic benefits and sit outside the definition of ecosystem benefit.
Refer to our website for more information.
The Innovation Ecosystem diagram is not assigning any difference in importance to anything shown. Generally an innovation ecosystem is a network of people, organisations and resources, including other current and future innovators operating within or outside of your supply/value chain. The stacked list shows six types of benefits (in no particular order) that can be created by a novel innovation, anywhere in the innovation ecosystem.
Absolutely. Benefits can be hard to predict with absolute certainty - and will not always have irrefutable proof that they will be realised. However, you may have an idea and have some evidence to assume they could be realised.
Applicants can provide their views of why they think those benefits are plausible and/or likely.
Motivated applicants may wish to back their views up with something like a letter from a reputable industry body, endorsing their innovation and the benefits they also believe will be generated for the innovation ecosystem. That option is open for applicants during the application process.
The elements of the innovation ecosystem which apply to each innovation vary widely depending on the area. Generally an innovation ecosystem is a network of people, organisations and resources, including other current and future innovators, operating within or outside of your supply/value chain. Another way to think about this is what is something that your project/innovation will do that will make it easier for future innovators like you to be successful. To help with framing your response in this space you could start with:
“Other innovators in Aotearoa-NZ will be able to do x,y,z due to our project which they weren't able to do before…”
Refer to the website for more information.
Refer to the Full Grant Assessment Framework on the website.
Other Questions
The first part is quite clear, and makes sense, but can you please clarify the last part of this? For example, if we have a project that is going to take 24 months, and we make some sales during that time, does this mean the rest of the funding stops? This is quite important for us (and I'd imagine other companies to understand) because if you can have a customer pay for even an earlier or MVP version of your product, that is strong validation you are on the right track, but it would put us in a difficult position it meant that the agreed grant funding stopped. You mention "pre-sales" and "paid pre-market trials" - so maybe there is the intention that so revenue could be generated?
We recognise that first sales in the form of paid trials and pre-sales are a key part of the launch journey of any new innovation and validating its potential in market, accordingly these would not lead to the cessation of your grant. Generally, pre-market trials take place in a limited way - whether it be limited volume/access, limited user functionality or MVP feature sets this is generally distinct from what we would consider "fully in market" where a product is sold and marketed widely in its final form.
There is no limit on overseas activities however please see page 12 of eligible cost guidance for greater detail. Reference link here.
You should address this in section 3.2.4 of your application specifically outlining: Why it's essential to perform those activities overseas, and why performing the activities overseas won't compromise your innovation’s potential to deliver benefits to the Aotearoa New Zealand innovation ecosystem. If you are unable to provide compelling reasoning as to how this would not compromise your innovations potential benefits to the New Zealand Innovation ecosystem it may lower your score against that criteria.
Essentially, my question is whether we are allowed successful sales outside our key target markets (EU and the US) during the grant period, or whether we must not have any sales in any markets at all.
The criteria is designed for premarket product launch, if you have a sale in place, the product is in market, regardless of whether this is target market or not.
You cannot be in the market with the specific innovation at the time of application. Pre-sales and paid pre-market trials are fine to be undertaken and supported with Ārohia funds, however once the innovation is fully in market, your funding would cease. The intent of Ārohia is to support companies seeking to take their innovation to market for the first time, hence we wouldn't continue to fund you through this scheme once you were in market.
That could be a valid benefit. However, in assessing this category, our assessors will consider the evidence regarding how your successful project will inspire others to innovate.
Because you are competing against other applicants, your application will only succeed if you can provide strong evidence of the breadth and impact of those benefit, not just that benefits are likely.
It is also worth noting that the Seed Grant exists in part to help customers gather such evidence before making a Full Grant application.
How you deliver your pitch is entirely up to you. The Panel will receive your application form as well as your live pitch.
If you feel that a demonstration adds value to your pitch to the Panel, your ability to convey your idea or potential benefits, then you're encouraged to do so. Do note that you must be able to do this within the 20 minute allocated time for your pitch.
Also note that the pitch will be virtual, via an online video call. So you will need to ensure that you have the capability to run the demonstration adequately from your end.
However, you will not be able to provide a demonstration to the internal Screening Committee that occurs before the Panel event.
Yes. You cannot be in the market with the specific innovation at the time of application. Pre-sales and paid pre-market trials are fine to be undertaken and supported with Ārohia funds, however once the innovation is fully in market, your funding would cease. The intent of Ārohia is to support companies seeking to take their innovation to market for the first time, hence we wouldn't continue to fund you through this scheme once you were in market.
Your business can be undertaking R&D activities while receiving Ārohia funding, however Ārohia funding can not be used to fund that R&D. Ārohia can however be spent on the broader innovation and commercialisation activities needed along side that R&D.
We will publish the panel list once the members have been selected.
Your application must cover one innovation. You cannot use the funding for other, different innovations but you may submit additional applications for the different innovations.
We do not sign non disclosure agreements with applicants however our staff, contractors and partners involved in the grants process are all subject to internal privacy and confidentiality policies and contractual obligations to ensure the safety of your IP. Ultimately we may find many applicants are able to submit successful applications for grants without disclosing the exact details of their core, sensitive IP and we recommend that you consider whether it is actually necessary to disclose this to us as part of your application. If your application is successful and we enter into a funding agreement with you, we will also ask your consent before sharing/publishing information, insights or case studies about your grant.
Seed Grant funds can also be used to apply for provisional patents to protect your IP if it is patentable and we offer the program Beyond IP to assist companies to establish an IP strategy. Refer to the website to learn more about Beyond IP.
A number of factors will influence how many grants are awarded, including timing of funding rounds, value of grants awarded compared to available funding and complexity of assessment. As this is the first round, a maximum of 10 applicants will be shortlisted.
Yes, we will work with successful recipients to develop case studies over time.
While we can't recommend individual providers, we have developed a pitch guidance document. Refer to this here.
Pre-sales and paid pre-market trials are fine to be undertaken and supported with Ārohia funds however once the innovation is fully in market your funding would cease. The intent of Ārohia is to support companies seeking to take their innovation to market for the first time hence we wouldn't continue to fund you through this scheme once you were in market. You could perhaps apply on the basis of the new innovations that are emerging if they are not already in play.
No, there is no industry level targeting to this fund at the present time.
Regulation development is the responsibility of regulators however in many cases industry, especially those at the bleeding edge, work with regulators to help them understand the scope of the activities that need to be regulated. This takes time and effort on behalf of the innovators, and creates efficiencies and frameworks for others that follow in your path, so is something that could be supported under Ārohia funding.
Other government funding cannot be used for the same activities however you may receive other funding to support other elements of getting your innovation to market. If you have other government funding you will need to demonstrate how you will not use this on the same activities applied for under the Ārohia Grant. Essentially you can't 'stack' or 'double dip funding' i.e. you can use Arohia to fund 30% of the costs of Activity A and NZTE funding to fund 30% of the cost of Activity B but you can't combine Arohia and NZTE funding to get 60% of either activity funded.
Pre-sales and paid pre-market trials are fine to be undertaken and supported with Ārohia funds however once the innovation is fully in market your funding would cease. The intent of Ārohia is to support companies seeking to take their innovation to market for the first time hence we wouldn't continue to fund you through this scheme once you were in market. You could perhaps apply on the basis of the new innovations that are emerging if they are not already in play.